Activation of PPARγ by 12/15-lipoxygenase during cerebral ischemia-reperfusion injury.

Peroxisome proliferator-activated receptor γ (PPARγ) expression and activity are increased in brain ischemic injury and its agonists have shown potential for brain injury protection. The influence of 12/15-lipoxygenase (12/15-LOX) on the activity of PPARγ in oxygen-glucose deprivation (OGD) and ischemia-reperfusion (I/R) was investigated. A middle cerebral artery occlusion/reperfusion model with Sprague Dawley (SD) rats was established. For I/R intervention, the rats were treated with the 12/15-LOX-derived product 12-hydroxyeicosatetraenoic acid (12-HETE) for 30 min before cerebral artery occlusion. Primary cortical neurons from SD rats were used to establish an OGD cell model. 12-HETE or a 12/15-LOX antisense oligonucleotide (asON-12/15-LOX) was added to OGD-treated neurons. Western blots, immunofluorescence and enzyme-linked immunosorbent assays detected protein. Reverse transcription-polymerase chain reaction analyzed the expression of the PPARγ target genes. PPARγ-DNA binding activity was determined by peroxisome proliferator responsive element luciferase reporter vectors. 12/15-LOX total protein increased significantly with I/R, and expression of 12-HETE was also upregulated. 12-HETE treatment increased PPARγ protein expression and inhibited inducible nitric oxide synthase protein expression, which was upregulated with I/R. PPARγ nuclear protein and 12/15-LOX total protein expression in OGD-treated neurons increased significantly. 12-HETE treatment increased the expression of PPARγ nuclear protein, upregulated the mRNA levels of PPARγ target genes (lipoprotein lipase and acyl-CoA oxidase) and enhanced PPARγ-DNA binding activity. asON-12/15-LOX treatment inhibited 12/15-LOX and PPARγ protein expression and lipoprotein lipase mRNA. Cerebral I/R injury in rats and OGD treatment in neurons promoted 12/15-LOX expression, and 12-HETE activated PPARγ. Therefore, PPARγ can be activated by the 12/15-LOX pathway during cerebral I/R injury.

[1]  D. Praticò,et al.  The 12‐15‐lipoxygenase is a modulator of Alzheimer's‐related tau pathology in vivo , 2013, Aging cell.

[2]  E. Lo,et al.  Following experimental stroke, the recovering brain is vulnerable to lipoxygenase‐dependent semaphorin signaling , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  Cristina Viéitez,et al.  Modelling Neuroinflammation In Vitro: A Tool to Test the Potential Neuroprotective Effect of Anti-Inflammatory Agents , 2012, PloS one.

[4]  R. Strosznajder,et al.  Evaluation of the antioxidative properties of lipoxygenase inhibitors , 2012, Pharmacological reports : PR.

[5]  M. Matsuda,et al.  Human catalase gene is regulated by peroxisome proliferator activated receptor-gamma through a response element distinct from that of mouse. , 2010, Endocrine journal.

[6]  Yan Cheng,et al.  12/15-Lipoxygenase inhibitor baicalein suppresses PPARγ expression and nuclear translocation induced by cerebral ischemia/reperfusion , 2010, Brain Research.

[7]  M. Sakharkar,et al.  Computational identification and experimental validation of PPRE motifs in NHE1 and MnSOD genes of Human , 2009, BMC Genomics.

[8]  J. Grotta,et al.  Neuronal PPARγ Deficiency Increases Susceptibility to Brain Damage after Cerebral Ischemia , 2009, The Journal of Neuroscience.

[9]  G. Weisinger,et al.  Lipoxygenase-derived metabolites are regulators of peroxisome proliferator-activated receptor gamma-2 expression in human vascular smooth muscle cells. , 2008, American journal of hypertension.

[10]  G. Bing,et al.  Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt , 2008, Journal of Neuroinflammation.

[11]  P. Boyle.  Diabetes mellitus and macrovascular disease: mechanisms and mediators. , 2007, The American journal of medicine.

[12]  D. Feinstein,et al.  Peroxisome proliferator‐activated receptor‐γ agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type‐2 diabetic rodents , 2006, Journal of neurochemistry.

[13]  J. Grotta,et al.  Neuronal expression of peroxisome proliferator-activated receptor-gamma (PPARγ) and 15d-prostaglandin J2—Mediated protection of brain after experimental cerebral ischemia in rat , 2006, Brain Research.

[14]  J. Roh,et al.  Peroxisome proliferator-activated receptor-γ-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia , 2006, Brain Research.

[15]  T. Herdegen,et al.  Activation of cerebral peroxisome proliferator‐activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase‐2 overexpression after focal cerebral ischemia in rats , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  O. Hurtado,et al.  Rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2 Cause Potent Neuroprotection after Experimental Stroke through Noncompletely Overlapping Mechanisms , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  C. Thiemermann,et al.  Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion. , 2006, European journal of pharmacology.

[18]  G. Landreth,et al.  Peroxisome proliferator-activated receptor-γ ligands reduce inflammation and infarction size in transient focal ischemia , 2005, Neuroscience.

[19]  J. Trojanowski,et al.  Elevation of 12/15 lipoxygenase products in AD and mild cognitive impairment , 2005, Annals of neurology.

[20]  Seung U. Kim,et al.  Thrombin-Induced Oxidative Stress Contributes to the Death of Hippocampal Neurons In Vivo: Role of Microglial NADPH Oxidase , 2005, The Journal of Neuroscience.

[21]  F. Terro,et al.  Blockade of 12-lipoxygenase expression protects cortical neurons from apoptosis induced by β-amyloid peptide , 2004, Cell Death and Differentiation.

[22]  J. Trojanowski,et al.  12/15-lipoxygenase is increased in Alzheimer's disease: possible involvement in brain oxidative stress. , 2004, The American journal of pathology.

[23]  A. Kannan,et al.  A Novel Pathway Involving Progesterone Receptor, 12/15-Lipoxygenase-derived Eicosanoids, and Peroxisome Proliferator-activated Receptor γ Regulates Implantation in Mice* , 2004, Journal of Biological Chemistry.

[24]  J. Leers,et al.  Activation of PPAR γ in colon tumor cell lines by oxidized metabolites of linoleic acid, endogenous ligands for PPAR γ , 2003 .

[25]  U. Dirnagl,et al.  Tolerance Against Ischemic Neuronal Injury Can Be Induced by Volatile Anesthetics and Is Inducible NO Synthase Dependent , 2002, Stroke.

[26]  S. Dobson,et al.  Regulation of VIP and other Neuropeptides by c‐Jun in Sensory Neurons: Implications for the Neuropeptide Response to Axotomy , 1996, The European journal of neuroscience.

[27]  J. Vallat,et al.  12-lipoxygenase mRNA expression by cultured neurons. , 1994, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[28]  J. Capone,et al.  Diverse peroxisome proliferator-activated receptors bind to the peroxisome proliferator-responsive elements of the rat hydratase/dehydrogenase and fatty acyl-CoA oxidase genes but differentially induce expression. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Roh,et al.  Peroxisome proliferator-activated receptor-gamma-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia. , 2006, Brain research.

[30]  J. Leers,et al.  Activation of PPAR gamma in colon tumor cell lines by oxidized metabolites of linoleic acid, endogenous ligands for PPAR gamma. , 2003, Carcinogenesis.